NZ625944A - Antibodies against cd38 for treatment of multiple myeloma - Google Patents
Antibodies against cd38 for treatment of multiple myelomaInfo
- Publication number
- NZ625944A NZ625944A NZ625944A NZ62594406A NZ625944A NZ 625944 A NZ625944 A NZ 625944A NZ 625944 A NZ625944 A NZ 625944A NZ 62594406 A NZ62594406 A NZ 62594406A NZ 625944 A NZ625944 A NZ 625944A
- Authority
- NZ
- New Zealand
- Prior art keywords
- seq
- human
- treatment
- antibodies against
- multiple myeloma
- Prior art date
Links
- 208000034578 Multiple myelomas Diseases 0.000 title 1
- 206010035226 Plasma cell myeloma Diseases 0.000 title 1
- 101000777636 Homo sapiens ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Proteins 0.000 abstract 6
- 102000052645 human CD38 Human genes 0.000 abstract 6
- 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 abstract 1
- 125000000404 glutamine group Chemical group N[C@@H](CCC(N)=O)C(=O)* 0.000 abstract 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N phenylalanine group Chemical group N[C@@H](CC1=CC=CC=C1)C(=O)O COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 abstract 1
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 abstract 1
Landscapes
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Life Sciences & Earth Sciences (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200500429 | 2005-03-23 | ||
| US66757905P | 2005-04-01 | 2005-04-01 | |
| US69616305P | 2005-07-01 | 2005-07-01 | |
| US72856105P | 2005-10-20 | 2005-10-20 | |
| NZ600059A NZ600059A (en) | 2005-03-23 | 2006-03-23 | Antibodies against cd38 for treatment of multiple myeloma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ625944A true NZ625944A (en) | 2016-01-29 |
Family
ID=50644285
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ625944A NZ625944A (en) | 2005-03-23 | 2006-03-23 | Antibodies against cd38 for treatment of multiple myeloma |
| NZ600059A NZ600059A (en) | 2005-03-23 | 2006-03-23 | Antibodies against cd38 for treatment of multiple myeloma |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ600059A NZ600059A (en) | 2005-03-23 | 2006-03-23 | Antibodies against cd38 for treatment of multiple myeloma |
Country Status (11)
| Country | Link |
|---|---|
| KR (1) | KR20140033240A (pl) |
| DK (1) | DK1866338T3 (pl) |
| ES (2) | ES2644982T3 (pl) |
| HU (2) | HUE030783T2 (pl) |
| LT (2) | LT1866338T (pl) |
| NZ (2) | NZ625944A (pl) |
| PL (1) | PL1866338T3 (pl) |
| PT (2) | PT1866338T (pl) |
| RS (1) | RS55442B1 (pl) |
| SG (1) | SG10201610317VA (pl) |
| UA (2) | UA116520C2 (pl) |
-
2006
- 2006-03-23 UA UAA201204050A patent/UA116520C2/uk unknown
- 2006-03-23 UA UAA200711639A patent/UA98756C2/ru unknown
- 2006-03-23 RS RS20161147A patent/RS55442B1/sr unknown
- 2006-03-23 KR KR1020147004315A patent/KR20140033240A/ko not_active Application Discontinuation
- 2006-03-23 LT LTEP06722861.9T patent/LT1866338T/lt unknown
- 2006-03-23 PT PT67228619T patent/PT1866338T/pt unknown
- 2006-03-23 PL PL06722861T patent/PL1866338T3/pl unknown
- 2006-03-23 ES ES12178778.2T patent/ES2644982T3/es active Active
- 2006-03-23 HU HUE06722861A patent/HUE030783T2/en unknown
- 2006-03-23 LT LTEP12178778.2T patent/LT2567976T/lt unknown
- 2006-03-23 HU HUE12178778A patent/HUE034962T2/en unknown
- 2006-03-23 DK DK06722861.9T patent/DK1866338T3/da active
- 2006-03-23 NZ NZ625944A patent/NZ625944A/en unknown
- 2006-03-23 PT PT121787782T patent/PT2567976T/pt unknown
- 2006-03-23 NZ NZ600059A patent/NZ600059A/en not_active Application Discontinuation
- 2006-03-23 SG SG10201610317VA patent/SG10201610317VA/en unknown
- 2006-03-23 ES ES06722861.9T patent/ES2606762T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| DK1866338T3 (da) | 2017-01-02 |
| LT1866338T (lt) | 2017-01-25 |
| SG10201610317VA (en) | 2017-02-27 |
| RS55442B1 (sr) | 2017-04-28 |
| LT2567976T (lt) | 2017-12-11 |
| PT1866338T (pt) | 2016-12-14 |
| KR20140033240A (ko) | 2014-03-17 |
| ES2644982T3 (es) | 2017-12-01 |
| UA116520C2 (uk) | 2018-04-10 |
| PT2567976T (pt) | 2017-10-19 |
| ES2606762T3 (es) | 2017-03-27 |
| HUE030783T2 (en) | 2017-06-28 |
| HUE034962T2 (en) | 2018-03-28 |
| PL1866338T3 (pl) | 2017-04-28 |
| NZ600059A (en) | 2016-01-29 |
| UA98756C2 (ru) | 2012-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG10201407388XA (en) | Humanized anti-cxcr5 antibodies, derivatives thereof and their uses | |
| MX2012004258A (es) | Inhibidores de la tirosina quinasa de bruton. | |
| MX2009010284A (es) | Inhibidores de la tirosina-cinasa de bruton. | |
| NZ597023A (en) | Monoclonal antibodies that bind to hGM-CSF and medical compositions comprising same | |
| GEP20156214B (en) | Monoclonal antibodies | |
| NZ716587A (en) | Antibodies specific for claudin 6 (cldn6) | |
| MX2014000518A (es) | Inhibidores de la tirosina quinasa de bruton. | |
| MX2009012949A (es) | Anticuerpos humanizados que enlazan a ab (1-42) globulomero y usos de los mismos. | |
| MX2008008298A (es) | Sal de sulfato de hidrogeno novedosa. | |
| MX2009004532A (es) | Composiciones y metodos para unir esfingosina-1-fosfato. | |
| NZ599140A (en) | Antibodies that specifically bind to the epha2 receptor | |
| CR20110606A (es) | Uso de un anticuerpo anti-tau ps422 para el tratamiento de enfermedades cerebrales | |
| NZ595825A (en) | Antibody containing igg2 having amino acid mutation introduced therein | |
| NZ623319A (en) | Human antibodies that bind lymphocyte activation gene-3 (lag-3), and uses thereof | |
| TW200727791A (en) | Materials and methods for improving livestock productivity | |
| MX2009005743A (es) | Nuevos anticuerpos monoclonales de globulomero anti-ab selectivos del conformero ab. | |
| UA101487C2 (en) | Humanized b-ly1 antibody formulation | |
| EA200702180A1 (ru) | Способы лечения иммунных нарушений, связанных с пересадкой трансплантата, растворимым мутантным ctla4 | |
| TW200617019A (en) | A process for the preparation of 7α-alkylated 19-norsteroids | |
| IL189452A0 (en) | Therapy with cd4 binding peptides and radiation | |
| IL163902A0 (en) | Antibodies against cancer antigen tmeff2 and uses thereof | |
| NZ595863A (en) | Antibodies to egfl7 and methods for their use | |
| UA94211C2 (ru) | Выделенное полностью человеческое моноклональное cd3 антитело | |
| MY142401A (en) | Materials and methods for improving shellfish heatlh, immunity and growth | |
| UA91733C2 (ru) | Способ получения кристаллической формы орлистата |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 9 YEARS UNTIL 23 MAR 2019 BY WATERMARK PATENT AND TRADE MARKS ATTORNEYS Effective date: 20160504 |
|
| S38C | Proceedings under section 38 (amendment of specification with leave of commissioner): specification amended | ||
| S38C | Proceedings under section 38 (amendment of specification with leave of commissioner): specification amended | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 23 MAR 2020 BY CPA GLOBAL Effective date: 20190208 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 23 MAR 2021 BY CPA GLOBAL Effective date: 20200206 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 23 MAR 2022 BY CPA GLOBAL Effective date: 20210204 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 23 MAR 2023 BY CPA GLOBAL Effective date: 20220204 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 23 MAR 2024 BY CPA GLOBAL Effective date: 20230210 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 23 MAR 2025 BY ABHISHEK KUMAR - CPA-PTO PAYMENTS Effective date: 20240208 |